Patient-based real-time quality control integrating neural networks and joint probability analysis

IF 3.2 3区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Clinica Chimica Acta Pub Date : 2025-02-01 DOI:10.1016/j.cca.2024.120112
Yong Xia , Wenbo Zheng , Hao Xue , Minxuan Feng , Qinxin Zhang , Bowen Li , Xin Li , Huan Qi , Yan Liu , Tony Badrick , Lei Zheng , Ling Ji
{"title":"Patient-based real-time quality control integrating neural networks and joint probability analysis","authors":"Yong Xia ,&nbsp;Wenbo Zheng ,&nbsp;Hao Xue ,&nbsp;Minxuan Feng ,&nbsp;Qinxin Zhang ,&nbsp;Bowen Li ,&nbsp;Xin Li ,&nbsp;Huan Qi ,&nbsp;Yan Liu ,&nbsp;Tony Badrick ,&nbsp;Lei Zheng ,&nbsp;Ling Ji","doi":"10.1016/j.cca.2024.120112","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Patient-based real-time quality control (PBRTQC) utilizes patient test results to continuously monitor laboratory test quality, addressing issues like discontinuities and matrix effects of traditional internal quality control. However, its clinical performance still requires enhancement. This study combined neural networks (NN) and joint probability analysis (NN-PBRTQC) to improve the clinical performance of PBRTQC.</div></div><div><h3>Methods</h3><div>Data were collected from Peking University Shenzhen Hospital and Nanfang Hospital Southern Medical University, which included a series of analytes. A neural network model was trained to predict the test results by integrating patient demographics. Residuals between the expected and actual test results were inputs for statistical process control algorithms to monitor analytical errors. Additionally, an intelligent alarm system using joint probability analysis was developed to reduce the false alarm rate (FAR). The performance of NN-PBRTQC was evaluated using FAR, and the number of patients until error detection was compared to traditional PBRTQC.</div></div><div><h3>Results</h3><div>NN-PBRTQC significantly enhanced the clinical performance of PBRTQC. Under the same desired FAR (DFAR) of 0.1 %, NN-PBRTQC required 64 % fewer samples for error detection than traditional PBRTQC for the analytes, which improved the sensitivity of error detection.</div></div><div><h3>Conclusion</h3><div>NN-PBRTQC provides a novel method for PBRTQC, effectively addressing sample variations and false alarms. It significantly reduces the false alarm rate and the sample size required for error detection, accelerating the implementation of PBRTQC in laboratories.</div></div>","PeriodicalId":10205,"journal":{"name":"Clinica Chimica Acta","volume":"567 ","pages":"Article 120112"},"PeriodicalIF":3.2000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Chimica Acta","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009898124023659","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

Patient-based real-time quality control (PBRTQC) utilizes patient test results to continuously monitor laboratory test quality, addressing issues like discontinuities and matrix effects of traditional internal quality control. However, its clinical performance still requires enhancement. This study combined neural networks (NN) and joint probability analysis (NN-PBRTQC) to improve the clinical performance of PBRTQC.

Methods

Data were collected from Peking University Shenzhen Hospital and Nanfang Hospital Southern Medical University, which included a series of analytes. A neural network model was trained to predict the test results by integrating patient demographics. Residuals between the expected and actual test results were inputs for statistical process control algorithms to monitor analytical errors. Additionally, an intelligent alarm system using joint probability analysis was developed to reduce the false alarm rate (FAR). The performance of NN-PBRTQC was evaluated using FAR, and the number of patients until error detection was compared to traditional PBRTQC.

Results

NN-PBRTQC significantly enhanced the clinical performance of PBRTQC. Under the same desired FAR (DFAR) of 0.1 %, NN-PBRTQC required 64 % fewer samples for error detection than traditional PBRTQC for the analytes, which improved the sensitivity of error detection.

Conclusion

NN-PBRTQC provides a novel method for PBRTQC, effectively addressing sample variations and false alarms. It significantly reduces the false alarm rate and the sample size required for error detection, accelerating the implementation of PBRTQC in laboratories.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinica Chimica Acta
Clinica Chimica Acta 医学-医学实验技术
CiteScore
10.10
自引率
2.00%
发文量
1268
审稿时长
23 days
期刊介绍: The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells. The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal''s scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.
期刊最新文献
Double-module ratio as a patient-based real-time quality control index for small shift detection and comparative assay. Novel biomarkers in bone pathophysiology: Establishing reference intervals and biological variations estimates for serum leptin, sclerostin, lipocalin-2, osteoprotegerin, resistin and Dickkopf-related protein-1 from the European biological variation study (EuBIVAS) populations. Screening and treatment of thalassemia The value of midregional proadrenomedullin to predict mortality in intensive care unit Application of volatilomic analysis by electronic nose for the detection of women with preeclampsia at high risk of developing chronic kidney disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1